Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combin...
Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )
10 Jul 2014
Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health...
Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France
Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )
10 Jul 2014
Drug repurposing as an alternative to costly drugs such as herceptin in breast c...
Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India
Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer ( Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India )
10 Jul 2014
Quality of life and cost advantages of metronomics and drug repurposing
Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK
Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )
10 Jul 2014
Diabetes drug, metformin, repurposed for use against several cancers including b...
Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy
Diabetes drug, metformin, repurposed for use against several cancers including breast ( Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy )
10 Jul 2014
Betablockers repurposed to treat neuroblastoma
Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia
Betablockers repurposed to treat neuroblastoma ( Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia )
10 Jul 2014
Advances in multiple myeloma: Expert panel discussion
Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios D...
Advances in multiple myeloma: Expert panel discussion ( Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios Dimopoulos )
3 Jul 2014
Industry view of targeted therapy combinations in oncology
Dr Susan Galbraith – AstraZeneca, Macclesfield, UK
Industry view of targeted therapy combinations in oncology ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )
26 Jun 2014
Impact of biomarker-integrated approaches of targeted therapy for lung cancer el...
Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA
Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
Networking and collaborating across borders in sub-Saharan Africa
Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Cent...
Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh -  Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )
26 Jun 2014
Genomic complexity of metastatic disease and the conundrum of combinations
Prof Razelle Kurzrock - University of California, San Diego, USA
Genomic complexity of metastatic disease and the conundrum of combinations ( Prof Razelle Kurzrock - University of California, San Diego, USA )
26 Jun 2014
Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Impli...
Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands
Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands )
26 Jun 2014